Compare Nucor Corporation (NUE) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nucor Corporation vs Tempus AI — how do they compare? Nucor Corporation trades at $257.93 (market cap $58.51B), while Tempus AI trades at $60.44 (market cap $11.13B). The key difference: Nucor Corporation is far larger — about 5.3× Tempus AI's market cap, and Nucor Corporation pays a 0.87% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| NUE | TEM | |
|---|---|---|
Market Cap | $58.51B | $11.13B |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $274.74 | $103.25 |
52-Week Low | $131.78 | $41.55 |
Enterprise Value | $62.92B | $11.75B |
Dividend Yield | 0.87% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Nucor (NUE) trades at $256.4, down 1.79% on the day, with a bullish technical signal and strong analyst support. Recent earnings beat expectations in Q1 and Q2 2026, and the stock benefits from positive sentiment around U.S. steel demand and tariff protections. The company maintains solid profitability with a net margin of 7.99% and ROE of 13.52%, though revenue has moderated from 2022 peaks.
Outlook is positive with a consensus price target of $281.38, implying ~10% upside. Key opportunities include infrastructure demand and new capacity, while risks involve cyclical steel industry pressures and volatile cash flows. Institutional buying, like CalSTRS' increased stake, supports confidence.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal from moving averages and RSI near oversold levels. The company reported a net loss of $245.03M in 2025 despite revenue of $1.27B, but recent quarterly EPS beats and FDA clearance for an AI-enabled ECG product (Business Wire, 2026-08-24) highlight growth potential in precision medicine. Analyst consensus is strongly bullish with a $69.20 price target.
Outlook: TEM's AI-driven healthcare platform positions it for long-term growth amid industry shifts toward personalized medicine, though persistent losses and high P/B of 25.01 pose valuation risks. Near-term catalysts include continued execution on recent contracts and pipeline developments, but investors face volatility from cash burn and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
